New drug duo takes on Hard-to-Treat kidney cancer
Disease control
Recruiting now
This early-phase trial is testing a new oral drug called HC-7366 combined with the approved drug belzutifan in about 80 adults with advanced kidney cancer that cannot be surgically removed. The main goal is to find the safest dose and check for any serious side effects. Researche…
Phase: PHASE1 • Sponsor: HiberCell, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC